Codexis, Inc. (CDXS) Reports First Quarter 2013 Results
5/8/2013 8:17:58 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the first quarter ended March 31, 2013.
“We are very encouraged by the continued growth of our pharmaceutical business during the first quarter, which demonstrated strong sales and profit expansion,” said John Nicols, President and CEO of Codexis.
Help employers find you! Check out all the jobs and post your resume.
comments powered by